The Art of Drug Synthesis (eBook, PDF)

Redaktion: Johnson, Douglas S.; Li, Jie Jack

• Format: PDF

Produktbeschreibung

The Art of Drug Synthesis illustrates how chemistry, biology, pharmacokinetics, and a host of other disciplines come together to produce successful medicines. The authors have compiled a collection of 21 representative categories of drugs, from which they have selected as examples many of the best-selling drugs on the market today. An introduction to each drug is provided, as well as background to the biology, pharmacology, pharmacokinetics, and drug metabolism, followed by a detailed account of the drug synthesis. * Edited by prominent scientists working in drug discovery for Pfizer * Meets the needs of a growing community of researchers in pharmaceutical R&D * Provides a useful guide for practicing pharmaceutical scientists as well as a text for medicinal chemistry students * An excellent follow-up to the very successful first book by these editors, Contemporary Drug Synthesis, but with all new therapeutic categories and drugs discussed.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Seitenzahl: 296
• Erscheinungstermin: 28. Juni 2008
• Englisch
• ISBN-13: 9780470134962
• Artikelnr.: 37290948

Autorenporträt

Douglas S. Johnson, PHD, is a Research Chemist at Pfizer Global Research and Development. Jie Jack Li, PHD, is a Research Chemist at Pfizer Global Research and Development.

Inhaltsangabe

Foreword. Preface. Contributors. 1 THE ROLE OF MEDICINAL CHEMISTRY IN DRUG
DISCOVERY (John A. Lowe, III). References. 2 PROCESS RESEARCH: HOW MUCH?
HOW SOON? (Neal G. Anderson). References. I CANCER AND INFECTIOUS DISEASES.
3 AROMATASE INHIBITORS FOR BREAST CANCER: EXEMESTANE (AROMASIN),
ANASTROZOLE (ARIMIDEX), AND LETROZOLE (FEMARA) (Jie Jack Li). References. 4
QUINOLONE ANTIBIOTICS: LEVOFLOXACIN (LEVAQUIN), MOXIFLOXACIN (AVELOX),
GEMIFLOXACIN (FACTIVE), AND GARENOXACIN (T-3811) (Chris Limberakis).
References. 5 TRIAZOLE ANTIFUNGALS: ITRACONAZOLE (SPORANOX), FLUCONAZOLE
(DIFLUCAN), VORICONAZOLE (VFEND), AND FOSFLUCONAZOLE (PRODIF) (Andrew S.
Bell). References. 6 NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE INHIBITORS
(Arthur Harms). References. 7 NEURAMINIDASE INHIBITORS FOR INFLUENZA:
OSELTAMIVIR PHOSPHATE (TAMIFLU) AND ZANAMIVIR (RELENZA) (Douglas S. Johnson
and Jie Jack Li). References. II CARDIOVASCULAR AND METABOLIC DISEASES. 8
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) AGONISTS FOR TYPE 2
DIABETES (Jin Li). References. 9 ANGIOTENSIN AT1 ANTAGONISTS FOR
HYPERTENSION (Larry Yet). References. 10 LEADING ACE INHIBITORS FOR
HYPERTENSION (Victor J. Cee and Edward J. Olhava). References. 11
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS FOR HYPERTENSION (Daniel P.
Christen). References. 12 SECOND-GENERATION HMG-CoA REDUCTASE INHIBITORS
(Jeffrey A. Pfefferkorn). References. 13 CHOLESTEROL ABSORPTION INHIBITORS:
EZETIMIBE (ZETIA) (Stuart B. Rosenblum). References. III CENTRAL NERVOUS
SYSTEM DISEASES. 14 DUAL SELECTIVE SEROTONIN AND NOREPINEPHRINE REUPTAKE
INHIBITORS (SSNRIs) FOR DEPRESSION (Marta Piñeiro-Núñez) References. 15
GABAA RECEPTOR AGONISTS FOR INSOMNIA: ZOLPIDEM (AMBIEN), ZALEPLON (SONATA),
ESZOPICLONE (ESTORRA, LUNESTA), AND INDIPLON (Peter R. Guzzo). References.
16 a2d LIGANDS: NEURONTIN (GABAPENTIN) AND LYRICA (PREGABALIN) (Po-Wai
Yuen). References. 17 APPROVED TREATMENTS FOR ATTENTION DEFICIT
HYPERACTIVITY DISORDER: AMPHETAMINE (ADDERALL), METHYLPHENIDATE (RITALIN),
AND ATOMOXETINE (STRATERRA) (David L. Gray). References. Index.

Rezensionen

Where I see the book being very useful is as a starting point for student seminars or discussion groups..." ( Chemistry World , February 2008)